Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On March 25, 2015, the Compensation Committee of the Board of Directors of WebMD Health Corp. approved the following grants of shares of restricted WebMD Common Stock and options to purchase WebMD Common Stock to executive officers of WebMD:
Executive Officer Title Number of Shares of
Restricted Stock Number of Shares
David Schlanger Chief Executive Officer 40,000 80,000
Steven Zatz, M.D. President 40,000 80,000
Peter Anevski Executive Vice President and Chief Financial Officer 40,000 80,000
Michael Glick Executive Vice President and Co-General Counsel 16,000 42,500
Douglas Wamsley Executive Vice President and Co-General Counsel 16,000 42,500
Martin J. Wygod Chairman of the Board 60,000 —
Tracey, yes, I agree with you. The partnership with WBA should be very interesting indeed, and the way the stock behaves in the face of adversity seems to indicate that there is some very cautious vacuum cleaning going on
Going on about the dead past with its shortcomings known to all is tiresome.
Big things are in the making:
Market watch: Lions Health Brings Google, WebMD, Walgreens, Novartis, Weber Shandwick and the CEA to the Stage
During the WebMD session at the Festival, Alex Gourlay, EVP Walgreens Boots Alliance, and president of Walgreens, will join WebMD CEO David Schlanger to examine what it will take for consumers to incorporate the necessary behavior changes they need to make to improve their health, Lion's Health announced.
Lions Health 2015 will be held June 19 and 20, Palais des Festivals, Cannes, France.
Sometimes it’s all a bit too much:
People worrying about a rise in interest rates when, in fact, that is a very good sign for an economy picking up…
People going on about a “strong” dollar when, in fact, it is just recovering a bit of the huge losses it had against serious currencies, as, for instance, the Swiss Franc…
People going on about WBMD being quiet - they quite obviously haven’t heard anything about option expiring dates…
Congratulations, you’re living up to your name
The agreement was done with “WebMD Health Services”, the WebMD unit that runs the private portals.
“The new partnership gives Michigan Blues' customers, including employer groups looking to keep costs down, the opportunity to incorporate wellness programs into their benefit structure.”
This says it quite clearly what this is all about!
Congratulations - It is good to see that someone else realises the importance of the Walgreens alliance for additional revenue sources outside advertising!
They were probably so embarrassed by being criticised on message boards they decided against bonuses for once.
Well, I never thought Marty was a fool.
What’s wrong with sticking to partnerships?
What would Marty do once somebody snatched his company?
At 75 you don’t start a new career.
That’s why I repeat what I said before:
This company is NOT for sale!
It should be obvious that the partnership with Walgreens is a game changer and will be responsible for much faster growth than we have seen so far.
That this is not yet included in the 2015 guidance is only due to the fact that probably nobody can estimate what it will be. I think the numbers could be staggering.
And on who’s table have you folks seen a buy-out project?
Marty is probably working on the big picture and leaves day-to-day business to the CEO, as he should, as Chairman of the Board. If he is confident that the CEO knows what he is doing, of course, which, apparently, he is.
After hours don’t mean a thing because of very limited volume and MMs doing their adjustments. Let’s wait for the opening.
For the year 2014
Adjusted EBITDA + 29%
Adjusted Net Income + 116%
or per diluted share + 148%
Guidance for the year 2015
Adjusted EBITDA + 13% to 20%
Net Income + 23% to 45%
There are some indicators that show us were the company is going:
1) The in-and-out of Icahn.
Carl Icahn is not a long term investor, but a short term opportunist who aims to profit from special situations.
He probably went into the company with the intention of forcing a sale and make a nice profit in the procedure. However, as he ran into opposition from Marty and his buddies, he preferred to sell his position to the company and walk away with a small profit or perhaps even a small loss.
For the combined know-how and connections of Marty and Icahn it shouldn’t have been any problem to find a suitable buyer for this company.
That a sale did not result should be indicator enough even to the most stubborn speculators that this company is not for sale.
The closest competitor is far smaller Everyday Health, a company that yet has to make a profit.
3) The partnership with Walgreens
When the leading health portal and the largest drug retailing chain in the United States, and perhaps the world, form a partnership, they don’t do it just to hold hands together but to increase revenues and profits for both of them.
Remember this exchange between an analyst and David Schlanger at the last earnings conference:
Are you thinking that (the partnership) more as a revenue generator? Or is it really more about the marketing presence, being in the stores? And do you see opportunities for this kind of partnership, either doing something deeper with Walgreens or with other partners?
Well, I would say yes to all of the above.
We are certainly pleased with the economic terms of the agreement.
We think it’s a terrific opportunity to leverage Walgreens’ substantial reach with consumers.
They get 8 million store visits a day, to make WebMD content and tools more accessible to people where they are.
And lastly, because of the breadth of Walgreens’ organization, we certainly see additional opportunities to work with them beyond what we’ve already contracted for.
After cooperating with Apple’s HealthKit and Qualcomm Life, this is an even more important step on WebMD’s way on becoming the octopus of healthcare.
“As expected this Leerink discussion with David Schlanger provided no greater insights into WebMD strategies for Revenue Enhancement…”
Which, of course, was hardly to be expected 13 days before their Fourth Quarter Earnings Release Date and Conference Call…
My point is that highly respected outfits like BlackRock and Vanguard don’t buy more than 5% of any company without having an in-depth discussion with that company’s management and without knowing exactly where those people are going.
As for yesterday’s announcement by Google I do hope you all listened to David Schlanger’s presentation at Leerink.
Institutional? With such small volume?
I don't think so!
WBMD's stength lies with Medscape, not with some gimmicks that can be copied by others. Just Watch tomorrows reply at Leerinks